Navigation Links
Rodobo International, Inc. to Present at Rodman & Renshaw Conference in Beijing on March 8, 2010
Date:3/5/2010

HARBIN, China, March 5 /PRNewswire-Asia-FirstCall/ -- Rodobo International, Inc. (OTC Bulletin Board: RDBO) ("Rodobo" or the "Company"), a U.S. company with wholly-owned fast growing Chinese operating companies engaged in the production, processing, distribution and development of high quality milk formula products in the People's Republic of China for infants, children, middle-aged and elderly, today announced that it will present at the Rodman & Renshaw Annual China Equities Conference. The conference will take place March 7-9, 2010, at the Regent Hotel in Beijing, China. Rodobo is scheduled to present in Ballroom 1 on Monday March 8, 2010 at 2:50 p.m. Beijing Time and the Company's Chairman and Chief Executive Officer, Mr. Wang Yanbin, and Chief Financial Officer, Ms. Xiuzhen Qiao will be in attendance. Investors interested in attending Rodman & Renshaw event should contact their Rodman & Renshaw sales representative. For more information about the conference, please visit

SOURCE Rodobo International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Rodobo International, Inc. Reports Q2 and First Half of 2009
2. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
3. Vita-Tech International, Inc. Donates One Ton of Vitamins To Polio Treatment Centers in Guinea, West Africa
4. HeartWare International, Inc. Temporary Suspension of Trading
5. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
6. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
7. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
8. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
9. Cryo-Cell International, Inc. Reports First Quarter 2009 Results
10. MINRAD International, Inc. Announces Reduction in Workforce
11. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... A study has been launched ... the Formula 1 track could help to tackle the ... Applied Technologies (MAT), Stowhealth (a GP surgery based in ... funded by healthcare provider Simplyhealth. Telemetry technology, ... about the on-track performance of Vodafone McLaren Mercedes Formula ...
(Date:1/15/2014)... 15, 2014 The Microcompetition with Foreign ... major disease. One of these latent viruses is the ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a ... predicted by the theory, a study found that RA ... bodies (1). , What is Microcompetition? , Dr. ...
(Date:1/15/2014)... January 15, 2014 Freeslate, ... research solutions, today announced that Lupin Limited, one ... delivery of Freeslate’s CM Protégé PharmD System ... , Lupin, headquartered in Mumbai, India, is focused ... and branded formulations and Active Pharmaceutical Ingredients (APIs) ...
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... national nonprofit organization solely dedicated to finding a cure ... for those affected worldwide, will host its annual Crystal ... in Warrington, Pa. , Each year, the Crystal ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... MEDX ) announced today that it has completed the ... stock is traded on the,Copenhagen Stock Exchange. The trade ... to receive approximately $151.8 million (USD) in net,proceeds from ... in Genmab to approximately 5.1 percent., About Medarex, ...
... Use of vitamin and mineral supplements,among cancer survivors ... beneficial, according to a comprehensive review of scientific,literature ... and published Feb. 1 in the Journal of ... reduce the adverse effects of,cancer treatment, decrease the ...
... 31 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX) today ... AppTec Laboratory,Services, Inc., a US-based service provider ... offers testing, contract research and,development, and cGMP ... integrated platform., (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ...
Cached Biology Technology:Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear 2Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear 3WuXi PharmaTech Completes Acquisition of AppTec 2
(Date:4/15/2014)... The American Association of Anatomists (AAA) is honored to ... be presented during the Closing Awards Ceremony being held ... 29th at 7:30 p.m. during AAA,s 2014 Annual Meeting ... award winners are: , Henry Gray/Elsevier Distinguished ... School of Medicine at Mount Sinai, Past-President of the ...
(Date:4/15/2014)... diseases in the world for which no pharmaceutical treatment ... spread by mosquitoes in the tropics, as well as ... Finland and is easily spread by the hands and ... elderly. , Researchers at Aalto University and the University ... to prevent the spread of one type of virus ...
(Date:4/15/2014)... Adelaide research into parasites of cuttlefish, squid and ... life cycles, and shown how they may help ... Dr Sarah Catalano has described 10 new parasite ... kidneys of cephalopods (cuttlefish, squid and octopus). ... be described from Australian waters. , "Although ...
Breaking Biology News(10 mins):American Association of Anatomists 2014 award winners 2Nanocrystalline cellulose modified into an efficient viral inhibitor 2Bizarre parasite may provide cuttlefish clues 2
... to control invasive winter moths with a natural parasite ... Massachusetts Amherst now has concrete evidence that a parasitic ... the pest at four sites in Seekonk, Hingham, Falmouth ... the decade-long defoliation of eastern Massachusetts trees by the ...
... Muslimov, MD, PhD, along with senior author Henri Tiedge, ... published a study suggesting that cellular dysregulation associated with ... neuronal RNA transport pathways. The paper appeared ... "Spatial Code Recognition in Neuronal RNA Targeting: Role of ...
... proteins whose activity and lifetime must be regulated to control the ... shock protein Hsp90 plays a key role in this process. It ... monitors and controls the quality and activity of many important signal ... cell is exposed to high stress levels from heat or a ...
Cached Biology News:UMass Amherst entomologists begin to control winter moth infestation in eastern Massachusetts 2Researchers publish study on neuronal RNA targeting 2A chaperone for the 'guardian of the genome' 2A chaperone for the 'guardian of the genome' 3
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
Human Complement Component C5a MAb (Clone 295003)...
Human Serpin A8/AGT Affinity Purified Polyclonal Ab Keywords: Ang II, AngII, Hypertension, Salt Homeostasis, Pre-eclampsia...
Mouse Axl MAb (Clone 175128)...
Biology Products: